Surgical results after primary decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage

Naoki Otani1, Hiroshi Nawashiro, Kojiro Wada

  • 1Department of Neurosurgery, National Defense Medical College, Saitama, Japan. naotani@ndmc.ac.jp

Insights

Decompressive craniectomy (DC) may improve outcomes for patients with poor-grade aneurysmal subarachnoid hemorrhage (SAH). This study suggests DC can reduce mortality and improve results in these critical cases.

Area of Science:

  • Neurosurgery
  • Neurology
  • Critical Care Medicine

Background:

  • Poor-grade aneurysmal subarachnoid hemorrhage (SAH) is associated with significant mass effect and brain stem compression, leading to poor patient outcomes.
  • Intracranial hypertension is a major challenge in managing SAH, often contributing to secondary brain injury.
  • Decompressive craniectomy (DC) is an established procedure for managing refractory intracranial hypertension.

Purpose of the Study:

  • To evaluate the efficacy of decompressive craniectomy (DC) in improving surgical outcomes for patients with poor-grade aneurysmal subarachnoid hemorrhage (SAH).
  • To assess the impact of DC on mortality and functional recovery in this specific patient cohort.

Main Methods:

  • Retrospective review of 15 patients who underwent DC for poor-grade SAH between August 2005 and July 2010.
  • Analysis of medical charts and radiological findings.
  • Assessment of patient outcomes using the Glasgow Outcome Scale (GOS) at discharge.

Main Results:

  • Among 15 DC patients, 1 (6.7%) had a good outcome, 6 (40.0%) moderate disability, 4 (28.1%) severe disability, 2 (13.3%) vegetative state, and 2 (13.3%) died.
  • Notably, 3 (50.0%) of the grade IV patients achieved a favorable outcome.
  • The overall mortality rate in the studied DC group was 13.3%.

Conclusions:

  • Decompressive craniectomy (DC) appears to be an effective intervention for reducing mortality in patients with poor-grade aneurysmal subarachnoid hemorrhage (SAH).
  • DC may offer improved outcomes, including favorable results in some severe cases (e.g., grade IV SAH).
  • Further research into the mechanisms, such as improved perfusion or reduced intracranial pressure, supports the use of DC in selected SAH patients.